Key Points:

• Representation Issue: Kevin Drizen seeks court permission to represent Glycobiosciences Inc. as a non-lawyer under Rule 15.01(2) of the Rules of Civil Procedure.
• Application Context: Drizen's application is for leave to represent Glycobiosciences in a different lawsuit (CV-23-197) against the same defendants.

Court Findings:

• Procedure Error: The court found Drizen should have sought leave through an interlocutory motion within action CV-23-197, not a new application.
• Abuse of Process: The court agreed with Respondents that Drizen’s new application was an attempt to circumvent a recent adverse ruling from the Court of Appeal denying him leave to represent Glycobiosciences.
• Legal Framework: The decision referenced Glycobiosciences Inc. v. Industria Farmaceutica Andromaco, S.A., de C.V. (2024 ONCA 481), which outlines the exceptional nature of granting leave to non-lawyers.

Conclusion:

• Application Dismissed: The court dismissed Drizen's application to represent Glycobiosciences as a non-lawyer.
• Costs: The court awarded substantial indemnity costs of $17,500 to the Respondents, payable by Glycobiosciences by August 29, 2024. The decision was influenced by Drizen's misuse of court procedures and the frivolous nature of the application.

Order Highlights:

• Dismissal without Prejudice: Drizen can still bring a proper motion in action CV-23-197.
• Costs Payable: Glycobiosciences must pay the awarded costs by the specified date.
• Further Order Details: Respondents’ counsel can draft the order without needing Drizen's approval.